CorMedix CRMD
NASDAQ CRMD
$8.20 -0.03 (-0.36%)
At close: Aug 21, 2026 · 4:00 PM EDT

CorMedix (CRMD) Change in Account Payables (2010 - 2025)

CorMedix (CRMD) posted Change in Account Payables of -$7.3 million for Q4 2025, down 211.79% sequentially from $6.5 million in Q3 2025, and down 2033.02% YoY from $375851.0 in Q4 2024.

CorMedix (CRMD) Change in Account Payables (2010 - 2025) Analysis & Trends

CorMedix has reported Change in Account Payables for 14 years, with the latest figure at -$7.3 million in Q4 2025.

  • Quarterly Change in Account Payables fell 2033.02% year-over-year to -$7.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.3 million (up 230.04% YoY) and the FY2025 annual result came in at $3.3 million, up 230.04% from the prior year.
  • Change in Account Payables slipped to -$7.3 million in Q4 2025 per CRMD's latest filing, from $6.5 million in the prior quarter.
  • Over five years, Change in Account Payables peaked at $6.5 million in Q3 2025 and troughed at -$7.3 million in Q4 2025.
  • A 4-year average of $252402.5 and a median of $375851.0 in 2024 frame the typical range for Change in Account Payables.
  • The widest YoY moves for Change in Account Payables: up 648.76% in 2025, down 2033.02% in 2025.
  • Over 4 years, Change in Account Payables stood at $434753.0 in 2022, then soared by 335.55% to $1.9 million in 2023, then plunged by 80.15% to $375851.0 in 2024, then slumped by 2033.02% to -$7.3 million in 2025.
  • According to Business Quant data, Change in Account Payables over the past three periods registered -$7.3 million, $6.5 million, and $3.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -66.70 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -8.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 37.53 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 CorMedix 645.20 Mn 388.51 Mn 77.13 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -7.27 Mn
Dec 31, 2025 -7.27 Mn
Sep 30, 2025 6.50 Mn
Sep 30, 2025 6.50 Mn
Jun 30, 2025 3.88 Mn
Jun 30, 2025 3.88 Mn
Mar 31, 2025 212,950.00
Mar 31, 2025 212,950.00
Dec 31, 2024 375,851.00
Dec 31, 2024 375,851.00
Sep 30, 2024 -2.00 Mn
Sep 30, 2024 -2.00 Mn
Jun 30, 2024 518,482.00
Jun 30, 2024 518,482.00
Mar 31, 2024 -1.45 Mn
Mar 31, 2024 -1.45 Mn
Dec 31, 2023 1.89 Mn
Dec 31, 2023 1.89 Mn
Sep 30, 2023 -514,450.00
Sep 30, 2023 -514,450.00